3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
7
Recruiting
4
Terminated
3
Unknown
2
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gynecologic
3
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
1
Interventions
Paclitaxel
69
Carboplatin
66
Cisplatin
36
pembrolizumab
34
Gemcitabine
24
liposomal doxorubicin
23
Cyclophosphamide
23
Topotecan
22
Bevacizumab
20
Taxes
14
Docetaxel
13
niraparib
12
Nivolumab
12
olaparib
10
fludarabine
10
Doxorubicin
9
Surveys and Questionnaires
8
Radiotherapy
8
Oxaliplatin
8
aldesleukin
7
Filgrastim
7
rucaparib
6
oregovomab
6
fludarabine phosphate
6
durvalumab
6
avelumab
6
Interleukin-2
6
Hyperthermic Intraperitoneal Chemotherapy
6
Fluorodeoxyglucose F18
6
Cytoreduction Surgical Procedures
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Conization
×
Gynecologic
×
Clear all
NCT06752135
2024-12-30
HRCC1
Azienda Policlinico Umberto I
Terminated
97 enrolled
NCT03852979
2020-01-10
NEOCON-F
The Netherlands Cancer Institute
Phase 2
Terminated
1 enrolled
NCT01283763
2016-11-01
ITIC2
Medical University of Vienna
Phase 3
Terminated
95 enrolled